| Followers | 48 |
| Posts | 23554 |
| Boards Moderated | 0 |
| Alias Born | 09/16/2012 |
Friday, November 07, 2025 10:13:06 AM
That’s just crazy talk
At that time she said bad actors turned “good news” into “bad news” and that happened because the “good news” was never disclosed to anyone publicly and those privately aware, time has shown us, were obviously not allowed to trade based on this information.
Yeah sure, great news! 🙄From their filing:
>>Since we did not enroll the last 17 of the planned 348 patients, this could adversely affect the statistical and other analyses of our Phase Ill trial results and could make it more difficult to seek product approval or more likely that further trials could be required. There can be no assurance that regulatory authorities will allow a product approval to be based upon this approach.
At that time she said bad actors turned “good news” into “bad news” and that happened because the “good news” was never disclosed to anyone publicly and those privately aware, time has shown us, were obviously not allowed to trade based on this information.
Yeah sure, great news! 🙄From their filing:
>>Since we did not enroll the last 17 of the planned 348 patients, this could adversely affect the statistical and other analyses of our Phase Ill trial results and could make it more difficult to seek product approval or more likely that further trials could be required. There can be no assurance that regulatory authorities will allow a product approval to be based upon this approach.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
